{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:52:57Z","timestamp":1786981977226,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11596-024-2830-1","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T06:03:26Z","timestamp":1708668206000},"page":"144-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Jianpi Qinghua Formula Alleviates Diabetic Myocardial Injury Through Inhibiting JunB\/c-Fos Expression"],"prefix":"10.1007","volume":"44","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-guang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"issue":"8","key":"2830_CR1","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","volume":"124","author":"WH Dillmann","year":"2019","unstructured":"Dillmann WH. Diabetic Cardiomyopathy. Circ Res, 2019,124(8):1160\u20131162","journal-title":"Circ Res"},{"issue":"29","key":"2830_CR2","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.2174\/1381612825666190830181944","volume":"25","author":"A Vecchi\u00e9","year":"2019","unstructured":"Vecchi\u00e9 A, Montecucco F, Carbone F, et al. Diabetes and Vascular Disease: Is It All About Glycemia. Curr Pharm Des, 2019,25(29):3112\u20133127","journal-title":"Curr Pharm Des"},{"issue":"2","key":"2830_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.rce.2019.10.013","volume":"222","author":"A Lorenzo-Almor\u00f3s","year":"2022","unstructured":"Lorenzo-Almor\u00f3s A, Cepeda-Rodrigo JM, Lorenzo \u00d3. Diabetic cardiomyopathy. Rev Clin Esp (Barc). 2022,222(2):100\u2013111","journal-title":"Rev Clin Esp (Barc)"},{"issue":"1","key":"2830_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","volume":"61","author":"G Jia","year":"2018","unstructured":"Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia, 2018,61(1):21\u201328","journal-title":"Diabetologia"},{"issue":"3","key":"2830_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","volume":"12","author":"G Jia","year":"2016","unstructured":"Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol, 2016,12(3):144\u2013153","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2830_CR6","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","volume":"57","author":"H Bugger","year":"2014","unstructured":"Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia, 2014,57(4):660\u2013671","journal-title":"Diabetologia"},{"issue":"4","key":"2830_CR7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.pcad.2019.03.003","volume":"62","author":"G Murtaza","year":"2019","unstructured":"Murtaza G, Virk H, Khalid M, et al. Diabetic cardiomyopathy - A comprehensive updated review. Prog Cardiovasc Dis, 2019,62(4):315\u2013326","journal-title":"Prog Cardiovasc Dis"},{"issue":"4","key":"2830_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity. Circ Res, 2018,122(4):624\u2013638","journal-title":"Circ Res"},{"issue":"1","key":"2830_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12906-022-03595-0","volume":"22","author":"Y Liu","year":"2022","unstructured":"Liu Y, Han X, Cai M, et al. Jianpi Qinghua Fomula alleviates insulin resistance via restraining of MAPK pathway to suppress inflammation of the small intestine in DIO mice. BMC Complement Med Ther, 2022,22(1):129","journal-title":"BMC Complement Med Ther"},{"issue":"1","key":"2830_CR10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/13880209.2023.2188549","volume":"61","author":"J Tian","year":"2023","unstructured":"Tian J, Cai M, Jin S, et al. JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK\/SIRTI\/NF-\u03baB pathway in high-fat-diet-fed C57BL\/6 mice. Pharm Biol, 2023,61(1):647\u2013656","journal-title":"Pharm Biol"},{"issue":"5","key":"2830_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1080\/10286020.2017.1405941","volume":"21","author":"MS Yin","year":"2019","unstructured":"Yin MS, Zhang YC, Xu SH, et al. Puerarin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of inflammation. J Asian Nat Prod Res, 2019,21(5):476\u2013493","journal-title":"J Asian Nat Prod Res"},{"key":"2830_CR12","doi-asserted-by":"publisher","first-page":"780419","DOI":"10.3389\/fphar.2021.780419","volume":"12","author":"YL Bai","year":"2021","unstructured":"Bai YL, Han LL, Qian JH, et al. Molecular Mechanism of Puerarin Against Diabetes and its Complications. Front Pharmacol, 2021,12:780419","journal-title":"Front Pharmacol"},{"issue":"8","key":"2830_CR13","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1142\/S0192415X18500891","volume":"46","author":"X Chen","year":"2018","unstructured":"Chen X, Yu J, Shi J. Management of Diabetes Mellitus with Puerarin, a Natural Isoflavone From Pueraria lobata. Am J Chin Med, 2018,46(8):1771\u20131789","journal-title":"Am J Chin Med"},{"key":"2830_CR14","doi-asserted-by":"publisher","first-page":"609134","DOI":"10.3389\/fendo.2021.609134","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Liu H, Zheng M, et al. Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota. Front Endocrinol (Lausanne), 2021,12:609134","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2830_CR15","doi-asserted-by":"publisher","first-page":"110984","DOI":"10.1016\/j.biopha.2020.110984","volume":"133","author":"X Xu","year":"2021","unstructured":"Xu X, Yi H, Wu J, et al. Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomed Pharmacother, 2021,133:110984","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"2830_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00395-004-0440-4","volume":"99","author":"MM El-Omar","year":"2004","unstructured":"El-Omar MM, Yang ZK, Phillips AO, et al. Cardiac dysfunction in the Goto-Kakizaki rat. A model of type II diabetes mellitus. Basic Res Cardiol, 2004,99(2):133\u2013141","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"2830_CR17","doi-asserted-by":"publisher","first-page":"E168","DOI":"10.1152\/ajpendo.00501.2007","volume":"294","author":"J Movassat","year":"2008","unstructured":"Movassat J, Bailb\u00e9 D, Lubrano-Berthelier C, et al. Follow-up of GK rats during prediabetes highlights increased insulin action and fat deposition despite low insulin secretion. Am J Physiol Endocrinol Metab, 2008,294(1):E168\u2013E175","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2830_CR18","doi-asserted-by":"publisher","first-page":"396414","DOI":"10.1155\/2015\/396414","volume":"2015","author":"S Korkmaz-Ic\u00f6z","year":"2015","unstructured":"Korkmaz-Ic\u00f6z S, Lehner A, Li S, et al. Mild Type 2 Diabetes Mellitus Reduces the Susceptibility of the Heart to Ischemia\/Reperfusion Injury: Identification of Underlying Gene Expression Changes. J Diabetes Res, 2015,2015:396414","journal-title":"J Diabetes Res"},{"issue":"19","key":"2830_CR19","doi-asserted-by":"publisher","first-page":"9376","DOI":"10.7150\/thno.64706","volume":"11","author":"Y Ding","year":"2021","unstructured":"Ding Y, Zhou Y, Ling P, et al. Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function. Theranostics, 2021,11(19):9376\u20139396","journal-title":"Theranostics"},{"issue":"5","key":"2830_CR20","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.7150\/ijbs.29680","volume":"15","author":"F Yang","year":"2019","unstructured":"Yang F, Qin Y, Wang Y, et al. Metformin Inhibits the NLRP3 Inflammasome via AMPK\/mTOR-dependent Effects in Diabetic Cardiomyopathy. Int J Biol Sci, 2019,15(5):1010\u20131019","journal-title":"Int J Biol Sci"},{"key":"2830_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3389\/fphys.2020.00425","volume":"11","author":"Z Yang","year":"2020","unstructured":"Yang Z, Wang M, Zhang Y, et al. Metformin Ameliorates Diabetic Cardiomyopathy by Activating the PK2\/PKR Pathway. Front Physiol, 2020,11:425","journal-title":"Front Physiol"},{"issue":"Suppl 1","key":"2830_CR22","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.2337\/diabetes.50.2007.S108","volume":"50","author":"ZC Ling","year":"2001","unstructured":"Ling ZC, Hong-Lie C, Ostenson CG, et al. Hyperglycemia contributes to impaired insulin response in GK rat islets. Diabetes, 2001,50 Suppl 1:S108\u2013S112","journal-title":"Diabetes"},{"issue":"5","key":"2830_CR23","first-page":"681","volume":"5","author":"SA Beddow","year":"2012","unstructured":"Beddow SA, Samuel VT. Fasting hyperglycemia in the Goto-Kakizaki rat is dependent on corticosterone: a confounding variable in rodent models of type 2 diabetes. Dis Model Mech, 2012,5(5):681\u2013685","journal-title":"Dis Model Mech"},{"issue":"6","key":"2830_CR24","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.2337\/db05-1526","volume":"55","author":"F Homo-Delarche","year":"2006","unstructured":"Homo-Delarche F, Calderari S, Irminger JC, et al. Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat. Diabetes, 2006,55(6):1625\u20131633","journal-title":"Diabetes"},{"issue":"6","key":"2830_CR25","first-page":"5784","volume":"18","author":"M Li","year":"2018","unstructured":"Li M, Fang H, Hu J. Apelin-13 ameliorates metabolic and cardiovascular disorders in a rat model of type 2 diabetes with a high-fat diet. Mol Med Rep, 2018,18(6):5784\u20135790","journal-title":"Mol Med Rep"},{"issue":"8","key":"2830_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1113\/expphysiol.2011.058446","volume":"96","author":"FC Howarth","year":"2011","unstructured":"Howarth FC, Qureshi MA, Sobhy ZH, et al. Structural lesions and changing pattern of expression of genes encoding cardiac muscle proteins are associated with ventricular myocyte dysfunction in type 2 diabetic Goto-Kakizaki rats fed a high-fat diet. Exp Physiol, 2011,96(8):765\u2013777","journal-title":"Exp Physiol"},{"issue":"6","key":"2830_CR27","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","volume":"51","author":"L Cai","year":"2002","unstructured":"Cai L, Li W, Wang G, et al. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes, 2002,51(6):1938\u20131948","journal-title":"Diabetes"},{"issue":"1","key":"2830_CR28","first-page":"58","volume":"8","author":"RH Han","year":"2021","unstructured":"Han RH, Huang HM, Han H, et al. Propofol postconditioning ameliorates hypoxia\/reoxygenation induced H9c2 cell apoptosis and autophagy via upregulating forkhead transcription factors under hyperglycemia. Mil Med Res, 2021,8(1):58","journal-title":"Mil Med Res"},{"issue":"3","key":"2830_CR29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/cells11030473","volume":"11","author":"E Zevolis","year":"2022","unstructured":"Zevolis E, Philippou A, Moustogiannis A, et al. The Effects of Mechanical Loading Variations on the Hypertrophic, Anti-Apoptotic, and Anti-Inflammatory Responses of Differentiated Cardiomyocyte-like H9C2 Cells. Cells, 2022,11(3):473","journal-title":"Cells"},{"key":"2830_CR30","doi-asserted-by":"publisher","first-page":"110026","DOI":"10.1016\/j.biopha.2020.110026","volume":"125","author":"K Szkudelska","year":"2020","unstructured":"Szkudelska K, Okulicz M, Hertig I, et al. Resveratrol ameliorates inflammatory and oxidative stress in type 2 diabetic Goto-Kakizaki rats. Biomed Pharmacother, 2020,125:110026","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"2830_CR31","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","volume":"126","author":"RH Ritchie","year":"2020","unstructured":"Ritchie RH, Abel ED. Basic Mechanisms of Diabetic Heart Disease. Circ Res, 2020,126(11):1501\u20131525","journal-title":"Circ Res"},{"issue":"10","key":"2830_CR32","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.3390\/cancers13102326","volume":"13","author":"F Fan","year":"2021","unstructured":"Fan F, Podar K. The Role of AP-1 Transcription Factors in Plasma Cell Biology and Multiple Myeloma Pathophysiology. Cancers (Basel), 2021,13(10):2326","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2830_CR33","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1038\/ncb0502-e131","volume":"4","author":"E Shaulian","year":"2002","unstructured":"Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol, 2002,4(5):E131\u2013E136","journal-title":"Nat Cell Biol"},{"key":"2830_CR34","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1042\/BST0360864","volume":"36","author":"M Piechaczyk","year":"2008","unstructured":"Piechaczyk M, Farr\u00e0s R. Regulation and function of JunB in cell proliferation. Biochem Soc Trans, 2008,36(Pt 5):864\u2013867","journal-title":"Biochem Soc Trans"},{"issue":"8","key":"2830_CR35","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/cdd.2014.53","volume":"21","author":"DA Cunha","year":"2014","unstructured":"Cunha DA, Gurzov EN, Naamane N, et al. JunB protects \u03b2-cells from lipotoxicity via the XBP1-AKT pathway. Cell Death Differ, 2014,21(8):1313\u20131324","journal-title":"Cell Death Differ"},{"issue":"1","key":"2830_CR36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1128\/MCB.19.1.330","volume":"19","author":"SJ Cook","year":"1999","unstructured":"Cook SJ, Aziz N, McMahon M. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol Cell Biol, 1999,19(1):330\u2013341","journal-title":"Mol Cell Biol"},{"issue":"20","key":"2830_CR37","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1038\/sj.onc.1202647","volume":"18","author":"K Balmanno","year":"1999","unstructured":"Balmanno K, Cook SJ. Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene, 1999,18(20):3085\u20133097","journal-title":"Oncogene"},{"key":"2830_CR38","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.phrs.2018.11.001","volume":"139","author":"S Tasneem","year":"2019","unstructured":"Tasneem S, Liu B, Li B, et al. Molecular pharmacology of inflammation: Medicinal plants as anti-inflammatory agents. Pharmacol Res, 2019,139:126\u2013140","journal-title":"Pharmacol Res"},{"issue":"5","key":"2830_CR39","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol, 2021,18(5):1106\u20131121","journal-title":"Cell Mol Immunol"},{"issue":"6571","key":"2830_CR40","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1126\/science.abi5200","volume":"374","author":"R Medzhitov","year":"2021","unstructured":"Medzhitov R. The spectrum of inflammatory responses. Science, 2021,374(6571):1070\u20131075","journal-title":"Science"},{"issue":"1","key":"2830_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/154405910608500103","volume":"85","author":"DT Graves","year":"2006","unstructured":"Graves DT, Liu R, Alikhani M, et al. Diabetes-enhanced inflammation and apoptosis\u2014impact on periodontal pathology. J Dent Res, 2006,85(1):15\u201321","journal-title":"J Dent Res"},{"issue":"6","key":"2830_CR42","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.immuni.2019.05.020","volume":"50","author":"N Van Opdenbosch","year":"2019","unstructured":"Van Opdenbosch N, Lamkanfi M. Caspases in Cell Death, Inflammation, and Disease. Immunity, 2019.50(6):1352\u20131364","journal-title":"Immunity"},{"issue":"9","key":"2830_CR43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri3495","volume":"13","author":"JS Arthur","year":"2013","unstructured":"Arthur JS, Ley SC. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol, 2013,13(9):679\u2013692","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2830_CR44","doi-asserted-by":"publisher","first-page":"E201","DOI":"10.1152\/ajpendo.00497.2011","volume":"302","author":"JA Kim","year":"2012","unstructured":"Kim JA, Jang HJ, Martinez-Lemus LA, et al. Activation of mTOR\/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation. Am J Physiol Endocrinol Metab, 2012,302(2):E201\u2013E208","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2830_CR45","doi-asserted-by":"publisher","first-page":"18946","DOI":"10.1038\/srep18946","volume":"6","author":"L Peng","year":"2016","unstructured":"Peng L, Zhou Y, Dong L, et al. TGF-\u03b21 Upregulates the Expression of Triggering Receptor Expressed on Myeloid Cells 1 in Murine Lungs. Sci Rep, 2016,6:18946","journal-title":"Sci Rep"},{"issue":"3","key":"2830_CR46","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cellsig.2013.12.002","volume":"26","author":"K Huang","year":"2014","unstructured":"Huang K, Huang J, Chen C, et al. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose. Cell Signal, 2014,26(3):629\u2013638","journal-title":"Cell Signal"},{"issue":"1","key":"2830_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/1947601912448820","volume":"3","author":"MI Kang","year":"2012","unstructured":"Kang MI, Baker AR, Dextras CR, et al. Targeting of Noncanonical Wnt5a Signaling by AP-1 Blocker Dominant-Negative Jun When It Inhibits Skin Carcinogenesis. Genes Cancer, 2012,3(1):37\u201350","journal-title":"Genes Cancer"},{"issue":"12","key":"2830_CR48","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3390\/ijms17122001","volume":"17","author":"Z Xu","year":"2016","unstructured":"Xu Z, Sun J, Tong Q, et al. The Role of ERK1\/2 in the Development of Diabetic Cardiomyopathy. Int J Mol Sci, 2016,17(12):2001","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2830_CR49","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3390\/ijms17071037","volume":"17","author":"S Wang","year":"2016","unstructured":"Wang S, Ding L, Ji H, et al. The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy. Int J Mol Sci, 2016,17(7):1037","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2830_CR50","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol, 2020,21(10):607\u2013632","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"19","key":"2830_CR51","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1038\/sj.onc.1204389","volume":"20","author":"W Jochum","year":"2001","unstructured":"Jochum W, Passegu\u00e9 E, Wagner EF. AP-1 in mouse development and tumorigenesis. Oncogene, 2001,20(19):2401\u20132412","journal-title":"Oncogene"},{"issue":"1","key":"2830_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.onc.1209759","volume":"26","author":"BW Ozanne","year":"2007","unstructured":"Ozanne BW, Spence HJ, McGarry LC, et al. Transcription factors control invasion: AP-1 the first among equals. Oncogene, 2007,26(1):1\u201310","journal-title":"Oncogene"},{"issue":"39","key":"2830_CR53","doi-asserted-by":"publisher","first-page":"14114","DOI":"10.1073\/pnas.0406061101","volume":"101","author":"CR Weston","year":"2004","unstructured":"Weston CR, Wong A, Hall JP, et al. The c-Jun NH2-terminal kinase is essential for epidermal growth factor expression during epidermal morphogenesis. Proc Natl Acad Sci U S A, 2004,101(39):14114\u201314119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"2830_CR54","first-page":"1498","volume":"56","author":"LI Junyan","year":"2015","unstructured":"Junyan LI, Feng T, Qingguang C, et al. Effect of Jianpi Qinghua Recipe on Gene Expression Profile and Signal Pathway of Type 2 Diabetes Mellitus Rats. J Tradit Chin Med (Chinese), 2015,56(17):1498\u20131501","journal-title":"J Tradit Chin Med (Chinese)"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2830-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-024-2830-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-024-2830-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T11:12:10Z","timestamp":1708686730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-024-2830-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2830"],"URL":"https:\/\/doi.org\/10.1007\/s11596-024-2830-1","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"20 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}